Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 38201 - 38220 out of 558245 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex 400 mg/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 400 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex 400 mg/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 400 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex 400 mg/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 400 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex 400 mg/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 400 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex 400 mg/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 400 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex 400 mg/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 400 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex 400 mg/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 400 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex 400 mg/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 400 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex 400 mg/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 400 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex 400 mg/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 400 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex 400 mg/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 400 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex 400 mg/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 400 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex 400 mg/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 400 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
Pages
